Innovent Biologics Market Cap

Innovent Biologics has a market cap or net worth of 162.80 billion as of September 24, 2025. Its market cap has increased by 135.40% in one year.

Market Cap

162.80B

Enterprise Value

156.05B

Revenue

12.52B

Ranking

n/a

PE Ratio

128.57

Stock Price

94.60

Market Cap Chart

Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 162.80B, an increase of 778.13%. That is a compound annual growth rate of 36.98%.

Market Cap History

Date	Market Cap	% Change
Sep 24, 2025	162.80B	171.53%
Dec 31, 2024	59.96B	-13.32%
Dec 29, 2023	69.17B	34.57%
Dec 30, 2022	51.40B	-27.14%
Dec 31, 2021	70.55B	-38.71%
Dec 31, 2020	115.10B	243.36%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Oct 31, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	281.72B
JD Health International	215.14B
Hansoh Pharmaceutical Group Company	211.89B
WuXi Biologics	160.52B
Sino Biopharmaceutical	145.58B
Akeso	125.83B
Sichuan Kelun-Biotech Biopharmaceutical	119.74B
CSPC Pharmaceutical Group	108.27B

Market Cap Rankings